Copy

 
Pharmalot Ed Silverman

STAT Plus: A pharma effort to work with European officials to develop needed drugs is a ‘failure’

By Ed Silverman

Matt Dunham/AP

A new report concludes that a public-private partnership between the EU and European drug makers has "failed to meet the goals that justified it."

Read More

STAT Plus: Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.

By Nicholas Florko

Adobe

As the coronavirus disrupts global supply chains, lawmakers are calling on pharma to exclusively make medicines in the U.S. Pharma's pushing back.

Read More

Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year

By Matthew Herper

Kena Betancur/Getty Images

Merck has has announced it is developing two different vaccines for Covid-19 and is also licensing an oral drug that might treat the virus.

Read More

He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer

By Matthew Herper

Courtesy Ian Haydon

Clinical trials patients are usually faceless. With Modern's Covid-19 vaccine candidate, it has a much more visible advocate: trial volunteer Ian Haydon.

Read More

STAT Plus: ‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi

By Elizabeth Cooney

Kristoffer Tripplaar/Sipa via AP Images

Peter Adamson, a pediatric oncologist, brings urgency to his new role as Sanofi's research leader in cancer and pediatric innovation.

Read More

Tuesday, May 26, 2020

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2020, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>